Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases

被引：12
|
作者：
Stefan, Norbert [1 ,2 ]
Lonardo, Amedeo [3 ]
Targher, Giovanni [4 ,5 ]
机构：
[1] Univ Tubingen, Dept Internal Med 4, Div Endocrinol Diabetol & Nephrol, Tubingen, Germany
[2] Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis IDM, Tubingen, Germany
[3] Azienda Osped Univ Modena, Dept Internal Med, Modena, Italy
[4] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy
[5] IRCCS Sacro Cuore Don Calabria Hosp, Metab Dis Res Unit, Verona, Italy
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2024年 / 21卷 / 03期
关键词：
D O I：
10.1038/s41575-023-00880-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Steatotic liver disease has emerged as an important risk factor for cardiovascular disease, type 2 diabetes mellitus and chronic kidney disease. Successful treatment of steatotic liver disease might also be effective in preventing these cardiometabolic diseases.
引用
收藏
页码：136 / 137
页数：2
相关论文
共 50 条
  • [1] Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
    Norbert Stefan
    Amedeo Lonardo
    Giovanni Targher
    Nature Reviews Gastroenterology & Hepatology, 2024, 21 : 136 - 137
  • [2] Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors
    Capinha, Francisco
    Carvalhana, Sofia
    Cortez-Pinto, Helena
    DIGESTIVE DISEASES AND SCIENCES, 2025,
  • [3] The Role of Exercise in Steatotic Liver Diseases: An Updated Perspective
    Razzak, Iyiad Alabdul
    Fares, Ahmed
    Stine, Jonathan G.
    Trivedi, Hirsh D.
    LIVER INTERNATIONAL, 2025, 45 (01)
  • [4] Role of Neutrophils in the Development of Steatotic Liver Disease
    Choi, You-Jin
    Kim, Yeonsoo
    Hwang, Seonghwan
    SEMINARS IN LIVER DISEASE, 2024, 44 (03) : 300 - 318
  • [5] BROWN SEAWEEDS ACTIVATING LIVER X RECEPTORS: POTENTIAL ROLE IN THE PREVENTION OF NEURODEGENERATIVE AND CARDIOMETABOLIC DISEASES
    Mulder, M. T.
    Martens, N.
    Zhan, N.
    Voortman-Minderman, G.
    Liu, H.
    Kuipers, F.
    Jonker, H.
    Luetjohann, D.
    Vanmierlo, T.
    ATHEROSCLEROSIS, 2022, 355 : E175 - E176
  • [6] An intergenerational study of the prevalence and cardiometabolic significance of steatotic liver disease in adults in the Raine Study
    Ayonrinde, Oyekoya
    Adams, Leon
    Mori, Trevor
    Melton, Phillip
    Olynyk, John
    Zelesco, Marilyn
    Mould, Andrea
    Fiori, James
    Beilin, Lawrence
    Dwivedi, Girish
    Sanfilippo, Frank
    Welman, Christopher
    JOURNAL OF HEPATOLOGY, 2024, 80 : S483 - S483
  • [7] ASSESSING THE PREVALENCE OF CARDIOMETABOLIC RISK FACTORS IN PATIENTS REFERRED TO A STEATOTIC LIVER DISEASE CLINIC
    Almahanna, Yousef
    Almohsen, Ahmed
    Song, Yi Nong
    Bajunayd, Amani
    Kim, Jeemin
    Abaya, Adrienne
    Mortuza, Rokhsana
    Khan, Mohammad Qasim
    Arab, Juan Pablo
    HEPATOLOGY, 2024, 80 : S919 - S919
  • [8] YOGURT INTAKE AND PREVENTION OF CARDIOMETABOLIC DISEASES: THE ROLE OF FERMENTATION PRODUCTS
    Marette, Andre
    ANNALS OF NUTRITION AND METABOLISM, 2017, 71 : 1330 - 1330
  • [9] Steatotic liver disease
    Israelsen, Mads
    Francque, Sven
    Tsochatzis, Emmanuel A.
    Krag, Aleksander
    LANCET, 2024, 404 (10464): : 1761 - 1778
  • [10] Cardiometabolic disease in the older person: prediction and prevention for the generalist physician
    Sinclair, Alan J.
    Abdelhafiz, Ahmed H.
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2020, 9 (03): : 90 - 95
12345